Issue 37, 2023

Bismuth-based two-dimensional nanomaterials for cancer diagnosis and treatment

Abstract

The intrinsic high X-ray attenuation and insignificant biological toxicity of Bi-based nanomaterials make them a category of advanced materials in oncology. Bi-based two-dimensional nanomaterials have gained rapid development in cancer diagnosis and treatment owing to their adjustable bandgap structure, high specific surface area and strong NIR absorption. In addition to the single functional cancer diagnosis and treatment modalities, Bi-based two-dimensional nanomaterials have been certified for accomplishing multi-imaging guided multifunctional synergistic cancer therapies. In this review, we summarize the recent progress including controllable synthesis, defect engineering and surface modifications of Bi-based two-dimensional nanomaterials for cancer diagnosis and treatment in the past ten years. Their medical applications in cancer imaging and therapies are also presented. Finally, we discuss the potential challenges and future research priorities of Bi-based two-dimensional nanomaterials.

Graphical abstract: Bismuth-based two-dimensional nanomaterials for cancer diagnosis and treatment

Article information

Article type
Review Article
Submitted
08 7 2023
Accepted
21 8 2023
First published
21 8 2023

J. Mater. Chem. B, 2023,11, 8866-8882

Bismuth-based two-dimensional nanomaterials for cancer diagnosis and treatment

C. Hong, T. Chen, M. Wu, J. Lin, C. Gao, X. Ma, Z. Liu, X. Yang and A. Wu, J. Mater. Chem. B, 2023, 11, 8866 DOI: 10.1039/D3TB01544K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements